Biotechnology News

February 14, 2013

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories: (STO:RAYB) JANUARY 1 – DECEMBER 31, 2012 · Net sales for the year amounted to SEK 182.1 M (126.1) · Profit after tax totaled SEK 19.9 M (17.0) and the result per share was of...

February 14, 2013

CROISSY-BEAUBOURG, France--(BUSINESS WIRE)--Regulatory News: Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a CE mark for two new biotherapy...

February 13, 2013

LINCOLN, Neb.--(BUSINESS WIRE)--Today, LI-COR® Biosciences continues to demonstrate its position as a leader in laboratory instrument systems as it announces the launch of the C-DiGit™ Blot Scanner.

February 13, 2013

SEATTLE--(BUSINESS WIRE)--CommonMind Consortium expands to include University of Pittsburgh, University of Texas Southwestern & Roche in a Public-Private Pre-Competitive Consortium to generate and share neuropsychiatric data.

February 13, 2013

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended December 31, 2012. Net revenues for the three months ended December 31, 2012, were approximately $3,856,000,...

February 13, 2013

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natera today announced the presentation of validation data demonstrating unmatched specificity and sensitivity of the company’s non-invasive prenatal test, Panorama™. The presentation, titled “Use of targeted...

February 13, 2013

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories reports fourth-quarter and full-year 2012 financial results

February 13, 2013

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the fourth quarter and year ended December 31, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial...

February 13, 2013

NEW YORK--(BUSINESS WIRE)--Deerfield announces $30 million investment in discovery labs

February 13, 2013

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Reports Fiscal 2013 First Quarter Financial Results and Hosts Conference Call Today at 4:30 p.m. Eastern Time

February 13, 2013

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced financial results for the three and 12 months ended December 31, 2012 and reviewed business highlights for the fourth quarter of 2012 and early 2013....

February 13, 2013

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its fourth quarter and year...

February 13, 2013

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the city of Tigre in the Province of Buenos Aires, has installed ZOLL AED Plus® units in public...

February 13, 2013

WASHINGTON--(BUSINESS WIRE)--With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities within emerging markets.

February 13, 2013

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--BioNJ installed Francois Nader, M.D., President and CEO of NPS Pharmaceuticals, as its news chairman and several new board members at its 20th Annual Meeting last week.

February 13, 2013

TRENTON, N.J.--(BUSINESS WIRE)--NORD, BioNJ and 11 New Jersey-based patient advocacy groups are joining forces for a unique educational event about rare diseases to be held at the New Jersey State House on March 4, 2013

February 13, 2013

PALO ALTO, Calif.--(BUSINESS WIRE)--Cancer Commons, the non-profit, open science initiative linking patients, physicians, and scientists, today announced the expansion of its cancer ecosystem Alliance with the addition of six prominent research...

February 13, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble preclinical data on advantages of novel macrocyclic compounds against challenging drug targets, including its first-in-class, orally active small molecule antagonists of IL-17

February 13, 2013

EWING, N.J.--(BUSINESS WIRE)--Proterro, the only biofuels company making sugar instead of extracting it from crops, names bioprocess eng. veteran Edi Eliezer vp/eng to develop pilot for affordable biofuels/biobased chem production

February 13, 2013

SAN CARLOS, Calif.--(BUSINESS WIRE)--Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today the appointment of William...

February 13, 2013

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced that it will be presenting at the 8th Annual New...

February 13, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, announced today a...

February 13, 2013

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its 2012 financial results on Thursday, February 21, 2013 at approximately 4:00 p.m. ET. The press release will be followed by a...

February 13, 2013

CONSHOHOCKEN, Pa. & SAN ANTONIO--(BUSINESS WIRE)--As health systems are under increasing pressure to share data across systems to improve and expand their networks of care, CardioNet, Inc. and AirStrip have entered into a partnership...

February 13, 2013

BRIDGEWATER, N.J.--(BUSINESS WIRE)--February 13, 2013--Dendreon Corporation (NASDAQ: DNDN) today announced that results from several ongoing or completed studies investigating the utility of PROVENGE® (sipuleucel-T) in the treatment of advanced...

February 13, 2013

NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals appoints Jane Henderson as Senior Vice President and Chief Business Officer.

February 13, 2013

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that food industry leader Dave Pfanzelter has been appointed to the Board of Directors. Mr....

February 13, 2013

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Brian Bollwage will present a live, interactive webinar titled “Coming to America: Regulatory Strategies for Foreign Drug and Device Companies” at 8 a.m. EST on Tuesday, Feb. 26.

February 13, 2013

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) announced today that new data from two Phase II studies on the effects of Capesaris® (GTx-758), a selective estrogen receptor alpha agonist, for the treatment of advanced prostate cancer,...

February 13, 2013

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it has closed its previously announced direct placement to leading healthcare investor, OrbiMed Israel Partners...

February 13, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced the company will present data on the latest developments related to its CertNDxTM Bladder Cancer Assays at two...

February 13, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today reported consolidated 2012 financial results and reviewed key recent accomplishments. “We continue to make significant progress with tivozanib, including reporting the final...

February 13, 2013

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the fourth quarter and full year ended December 31, 2012. “We are pleased with the performance of AMPYRA in 2012, and excited about...

February 13, 2013

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Retains New IR Group to Optimize Investor Outreach, Relay Key Growth Plans

February 13, 2013

PARIS--(BUSINESS WIRE)--Nanobiotix appoints Dr. Alain Herrera to the Supervisory Board

February 13, 2013

BEERSE, Belgium--(BUSINESS WIRE)--Note: Data in this release correspond to ASCO GU Abstract #5. Janssen Research & Development, LLC [Janssen] announced today long-term results showing ZYTIGA® (abiraterone acetate) plus prednisone continued to...

February 12, 2013

SAN DIEGO & ORLANDO, Fla.--(BUSINESS WIRE)--Epic Sciences is presenting a research poster at the 2013 Genitourinary Cancers Symposium taking place February 14 to 16 from 11:45 am to 1:15 pm EST in Gatlin Ballroom B in Orlando, Fla.

February 12, 2013

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio’s new Dip and Read™ Anti-FLAG Biosensor enables researchers to quickly and easily detect FLAG-tagged recombinant proteins for their quantitation and kinetic characterization.

February 12, 2013

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2012. The Form 20-F is available on Elan's website at...

February 12, 2013

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the fourth quarter and twelve months ended December 31, 2012. The company also highlighted ADCETRIS (brentuximab vedotin) commercialization...

February 12, 2013

SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced it will report financial results for its 2012 fourth quarter and full year ended December 31,...

February 12, 2013

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, announced today that enrollment in the Company’s SternaLock® Blu clinical trial has begun. The SternaLock® Blu clinical...

February 12, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2012. Q4 Product Revenue Up 25%; Full Year Product Revenue Up 27%

February 12, 2013

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering

February 12, 2013

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT Announces First Patient Enrolled in North American Clinical Trial of Mirasol® Pathogen Reduction Technology System

February 12, 2013

SANTA CLARA, Calif. & SALT LAKE CITY--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and Sera Prognostics Inc., a women’s health company, today announced a strategic partnership to develop proteomic assays for the early prediction of...